Market Tracker

02/24 5:16pm ET

Sucampo Pharmaceuticals Inc (NASDAQ:SCMP)

11.75
Delayed Data
As of Feb 24
 +0.05 / +0.43%
Today’s Change
9.59
Today|||52-Week Range
17.55
-13.28%
Year-to-Date
Shire (SHPG) Beats on Q4 Earnings, Sales; Gives Upbeat View
Feb 17 / Zacks.com - Paid Partner Content
Prothena (PRTA) Reports Wider-than-Expected Loss in Q4
Feb 15 / Zacks.com - Paid Partner Content
Zoetis (ZTS) Beats Q4 Earnings Estimates, Lowers Outlook
Feb 16 / Zacks.com - Paid Partner Content
Gilead (GILD) Announces Data on Combination Therapy for HIV
Feb 14 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close11.70
Today’s open11.55
Day’s range11.53 - 12.00
Volume629,980
Average volume (3 months)941,482
Market cap$538.6M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+151.72%
Earnings growth (this year)+27.38%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+32.68%
P/E ratio40.5
Price/Sales5.16
Price/Book6.19

Competitors

 Today’s
change
Today’s
% change
KERXKeryx Biopharmaceuti...+0.14+2.87%
ESPREsperion Therapeutic...-0.08-0.33%
ENTAEnanta Pharmaceutica...-0.25-0.89%
ACHNAchillion Pharmaceut...-0.38-8.96%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMarch 8, 2017
EPS forecast (this quarter)$0.48
Annual revenue (last year)$153.2M
Annual profit (last year)$33.4M
Net profit margin21.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Peter S. Greenleaf
Chief Financial Officer
Andrew P. Smith
Corporate headquarters
Rockville, Maryland

Forecasts